Washington, DC Bids > Bid Detail

Domestic Public Health Industrial Base Capabilities and Capacities: Essential Medicines, Medical Countermeasures, and Critical Inputs

Back Print
Agency:
Level of Government: Federal
Category:
  • 65 - Medical, Dental, and Veterinary Equipment and Supplies
Opps ID: NBD00159229449556965
Posted Date: Feb 26, 2024
Due Date: Mar 22, 2024
Source: https://sam.gov/opp/079813794c...
Follow
Domestic Public Health Industrial Base Capabilities and Capacities: Essential Medicines, Medical Countermeasures, and Critical Inputs
Active
Contract Opportunity
Notice ID
75A50120C
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office
INDUSTRIAL BASED MANUFACTURING AND SUPPLY CHAIN (IBMSC)
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information
  • Contract Opportunity Type: Sources Sought (Original)
  • All Dates/Times are: (UTC-05:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Original Published Date: Feb 26, 2024 10:22 am EST
  • Original Response Date: Mar 22, 2024 05:00 pm EDT
  • Inactive Policy: 15 days after response date
  • Original Inactive Date: Apr 06, 2024
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: 6505 - DRUGS AND BIOLOGICALS
  • NAICS Code:
    • 325411 - Medicinal and Botanical Manufacturing
  • Place of Performance:
    Washington , DC 20515
    USA
Description

The HHS DPA Title III Program provides this RFI to invite industry partners to submit to the USG information that will aid in improving the understanding of current domestic productive capabilities and capacities of the domestic PHIB for manufacturing used to produce and supply essential medicines, medical countermeasures, and critical inputs health resources considered essential to national defense, and to identify and improve on those gaps in the marketplace that can potentially be addressed using HHS’ delegated Title III authorities. Industry responses to the RFI are intended to assist the HHS DPA Title III Program with planning and market research.See the attached RFI and submit responses to Chris Newell at christopher.newell@hhs.gov.



.


Attachments/Links
Contact Information
Contracting Office Address
  • 400 7th St SW
  • Washington , DC 20024
  • USA
Primary Point of Contact
Secondary Point of Contact
History
  • Feb 26, 2024 10:22 am ESTSources Sought (Original)

TRY FOR FREE

Not a USAOPPS Member Yet?

Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.

Start Free Trial Today >